title: Compound heterozygosity of two functional null mutations in the ALPL gene associated with deleterious neurological outcome in an infant with hypophosphatasia.
abstract: Hypophosphatasia (HPP) is a heterogeneous rare, inherited disorder of bone and mineral metabolism caused by different mutations in the ALPL gene encoding the isoenzyme, tissue-nonspecific alkaline phosphatase (TNAP). Prognosis is very poor in severe perinatal forms with most patients dying from pulmonary complications of their skeletal disease. TNAP deficiency, however, may also result in neurological symptoms such as neonatal seizures. The exact biological role of TNAP in the human brain is still not known and the pathophysiology of neurological symptoms due to TNAP deficiency in HPP is not understood in detail. In this report, we describe the clinical features and functional studies of a patient with severe perinatal HPP which presented with rapidly progressive encephalopathy caused by new compound heterozygous mutations in the ALPL gene which result in a functional ALPL "knock out", demonstrated in vitro. In contrast, an in vitro simulation of the genetic status of his currently asymptomatic parents who are both heterozygous for one mutation, showed a residual in vitro AP activity of above 50%. Interestingly, in our patient, the fatal outcome was due to progressive encephalopathy which was refractory to antiepileptic therapy including pyridoxine, rather than hypomineralization and respiratory insufficiency often seen in HPP patients. The patient's cranial MRI showed progressive cystic degradation of the cortex and peripheral white matter with nearly complete destruction of the cerebrum. To our knowledge, this is the first MRI-based report of a deleterious neurological clinical outcome due to a progressive encephalopathy in an infant harboring a functional human ALPL "knock out". This clinical course of disease suggests that TNAP is involved in development and may be responsible for multiple functions of the human brain. According to our data, a certain amount of residual TNAP activity might be mandatory for normal CNS function in newborns and early childhood.
authors: Children's Hospital, University of Würzburg, Würzburg, Germany. hofmann_c5@klinik.uni-wuerzburg.de
authors: C
authors: C
authors: Hofmann
authors: J
authors: J
authors: Liese
authors: T
authors: T
authors: Schwarz
authors: S
authors: S
authors: Kunzmann
authors: J
authors: J
authors: Wirbelauer
authors: J
authors: J
authors: Nowak
authors: J
authors: J
authors: Hamann
authors: H
authors: H
authors: Girschick
authors: S
authors: S
authors: Graser
authors: K
authors: K
authors: Dietz
authors: S
authors: S
authors: Zeck
authors: F
authors: F
authors: Jakob
authors: B
authors: B
authors: Mentrup
mesh_terms: D000469:Alkaline Phosphatase / Q000235:genetics*; D001927:Brain Diseases / Q000235:genetics*; D017809:Fatal Outcome; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D057809:HEK293 Cells; D006579:Heterozygote; D006801:Humans; D007014:Hypophosphatasia / Q000201:enzymology / Q000235:genetics*; D007223:Infant; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging; D008297:Male; D050505:Mutant Proteins / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D021381:Protein Transport; D013347:Subcellular Fractions / Q000201:enzymology
chemical_list: D050505:Mutant Proteins; C548267:ALPL protein, human; D000469:Alkaline Phosphatase